Life sciences organizations have long struggled with fragmented, time-intensive processes for discovering, assessing, and purchasing real-world data (RWD). These bottlenecks delay evidence generation, slow clinical and commercial decision-making,…

As the healthcare data landscape continues to evolve and transform, the ability to discover and evaluate real-world data (RWD) with speed and precision is a critical advantage. For…

As the demand for high-quality real-world data (RWD) accelerates across the life sciences industry, so too does the urgency to solve the persistent friction in data discovery, access,…

In the high-stakes world of life sciences, where timelines are tight and data-driven decisions shape the success of therapies, time to insight can mean the difference between momentum…

In a fragmented and fast-moving policy environment, state legislatures are taking the lead on issues once governed almost exclusively at the federal level. From new rules on health…

Explore the key takeaways from ISPOR 2025, including how HEOR is evolving with AI, PETs, and cloud-first data access.

The volume of trials Datavant is tokenizing has grown 300%, reflecting an industry shift.

Learn how HEOR teams can accelerate dataset assessment, streamline access, and drive meaningful insights-all while supporting privacy compliance. Discover how Verana Health, Datavant, and AWS are enabling urology…